Phlebotomy Technician Program
Thursday 31 October 2019
Protagonist Therapeutics (PTGX) Begins Phase 2 Study of Novel Hepcidin Mimetic PTG-300 for Treatment of Patients with Polycythemia Vera - StreetInsider.com
Protagonist Therapeutics (PTGX) Begins Phase 2 Study of Novel Hepcidin Mimetic PTG-300 for Treatment of Patients with Polycythemia Vera
StreetInsider.com
from "phlebotomy" - Google News http://bit.ly/323LA5S
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment